1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Enasidenib is highly active in previously untreated IDH2 mutant AML: Early results from the Beat AML Master Trial
    Meeting Abstract

    Stein, E. M.; Shoben, A.; Borate, U.; Baer, M. R.; Stock, W.; Patel, P. A.; Kovacsovics, T.; Blum, W.; Vergilio, J. A.; Heerema, N. A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • RNA binding protein RBMX is required in acute myeloid leukemia by regulating the transcriptional activity of the heterochromatin protein HP1 alpha
    Meeting Abstract

    Prieto, C.; Nguyen, D.; Vu, L. P.; Perez, A.; Gourkanti, S.; Schurer, A.; Chou, T.; Chow, A.; Taggart, J.; Barlowe, T. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A next-generation sequencing-based karyotyping algorithm reveals the genomic structure of acute myeloid leukemia
    Meeting Abstract

    Pavlick, D.; Montesion, M.; Heerema, N. A.; Severson, E. A.; Brennan, T.; Frampton, G. M.; He, J.; Byrd, J. C.; Levine, R. L.; Burd, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Combinatorial genetics uncovers novel targets for the treatment of NPM1/cohesin mutated AML
    Meeting Abstract

    Meyer, A. E.; Stelloh, C.; Fisher, J. B.; Pulakanti, K.; Vassiliou, G. S.; Viny, A. D.; Levine, R. L.; Rao, S.
    Blood (2018)

    Fulltext@MSK | Save
  • A precision medicine heirarchical classification developed using variant allele frequency (VAF) for treatment of older patients (Pts) with acute myeloid leukemia (AML): Alliance Clinical Trials in Oncology (Alliance) historical patient control
    Meeting Abstract

    Mims, A. S.; Kohlschmidt, J.; Borate, U.; Norris, B.; Bucy, T.; Blachly, J. S.; Orwick, S.; Eisfeld, A. K.; Papaioannou, D.; Nicolet, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Epigenetic drug treatment induces presentation of new class of non-exonic cryptic neoantigens in acute myeloid leukemia cells
    Meeting Abstract

    Klatt, M. G.; Mun, S. S.; Socci, N. D.; Korontsvit, T.; Dao, T.; Scheinberg, D. A.
    Blood (2018)

    Fulltext@MSK | Save
  • Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome
    Meeting Abstract

    Labuhn, M.; Perkins, K.; Papaemmanuil, E.; Garnett, C.; Matzk, S.; Amstislavskiy, V.; Metzner, M.; Kennedy, A.; Scheer, C.; Yoshida, K.; more...
    Blood (2018)

    Fulltext@MSK | Save